Inventaire - i tuoi amici e le tue comunità sono la tua biblioteca

High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients

autore

Toyomasa Katagiri

pubblicato in: Breast Cancer Research and Treatment

data di pubblicazione: 2015-11-16

lingua: inglese

Cita articoli 16

Data

Titolo

Autori

2014-07-15

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

Caroline Wilson, Peter Barrett-Lee, Samantha Hinsley, Helen Marshall
2013-10-23

Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis
2011-10-10

Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.

Edith A. Perez
2011-09-25

Breast-cancer adjuvant therapy with zoledronic acid.

Helen Marshall, Peter Barrett-Lee
2011-06-27

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011-08-22

Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14

Kathleen I. Pritchard
2010-10-07

Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial.

Anthony Howell, Matthias W. Beckmann
2009-08-01

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
2009-09-03

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

Pierrick Fournier, Theresa A. Guise
2008-08-19

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

Michael Gnant
2007-07-01

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.
2005-12-01

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004.

Colin Dunstan
2005-09-07

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.
2003-11-01

Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth

Markus J Seibel
2001-08-01

Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients
1997-05-01

Diurnal variation of bone mineral turnover in elderly men and women.

Articolo - wd:Q41120073

Benvenuto su Inventaire

la biblioteca dei tuoi amici e della tua comunità

ulteriori informazioni